Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1(+) T lymphocyte niches through a feed-forward loop
Ciriolo, Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, 00133 Rome, Italy e-mail: [email protected] This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology
Marsico F, Paolillo S, Gargiulo P, Bruzzese D, DellAversana S, Esposito I, Renga F, Esposito L, Marciano C, Dellegrottaglie S, et al
Epithalon Strength: 20 mg A balanced mid-range option for patients exploring advanced wellness and rejuvenation support
Correct handling maintains integrity and reproducibility in research
Their wound-healing qualities help repair old, damaged tissue and encourage the regrowth of new, healthy tissue